港股异动 | 爱康医疗续涨逾8%创新高 上市2年已累涨近6倍
格隆汇1月15日丨“3D打印第一股”爱康医疗(1789.HK)今日续涨,盘中高见12.26港元创上市新高。现报12.18港元,涨8.56%,暂成交4887万港元,最新总市值128亿港元。爱康医疗本周一(13日)早间发公告称,于2020年1月9日,公司生产的3D打印定制式胸椎,在北京大学第三医院成功于手术中完成植入。该手术是2020年1月1日施行《定制式医疗器械监督管理规定(试行)》后,完成的第一台定制式医疗器械植入手术。值得一提的是,爱康医疗自2017年12月20日首日上市以来连年上涨,2017年累涨77%、2018年累涨44%、2019年累涨104%,2020年迄今半个月已累涨近40%。上市至今近25个月时间,现较招股价1.75港元已大涨近6倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.